The World Health Organization announced on Thursday the emergency registration of the anti-Covid vaccine Convidecia from Chinese laboratories CanSino Biologics, as Beijing battles against a resurgence of the pandemic.
Read alsoChina in the “
zero Covid
” trap
This vaccine is based on a modified human adenovirus, it is administered in a single dose and the WHO recommends it for all age groups from 18 years old, specifies a press release from the WHO.